adecatumumab

As nouns the difference between adecatumumab and null

is that adecatumumab is a recombinant monoclonal antibody used to target tumour cells while null is zero, nil; the cardinal number before einn.

As nouns the difference between terms and adecatumumab

is that terms is while adecatumumab is a recombinant monoclonal antibody used to target tumour cells.

As nouns the difference between cell and adecatumumab

is that cell is a single-room dwelling for a hermit or cell can be (us|informal) a cellular phone while adecatumumab is a recombinant monoclonal antibody used to target tumour cells.

As a verb cell

is to place or enclose in a cell.

As nouns the difference between tumour and adecatumumab

is that tumour is (oncology|pathology) an abnormal growth; differential diagnosis includes abscess, metaplasia, and neoplasia while adecatumumab is a recombinant monoclonal antibody used to target tumour cells.

As nouns the difference between recombinant and adecatumumab

is that recombinant is an organism, cell, or haplotype formed by genetic recombination while adecatumumab is a recombinant monoclonal antibody used to target tumour cells.

As an adjective recombinant

is referring to something formed by combining existing elements in a new combination. Especially in the phrase recombinant DNA referring to an organism created in the lab by adding DNA from another species.